Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
Clinical trial NCT02523599 · COMPLETED
Trial details
- NCT number
- NCT02523599
- Sponsor
- Innocoll
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-04-01
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.